- Report
- October 2020
- 18 Pages
France
From €2862EUR$2,995USD£2,435GBP
- Report
- October 2020
- 18 Pages
United Kingdom
From €2862EUR$2,995USD£2,435GBP
- Report
- October 2020
- 18 Pages
China
From €2862EUR$2,995USD£2,435GBP
- Report
- October 2020
- 18 Pages
South Korea
From €2862EUR$2,995USD£2,435GBP
- Report
- October 2020
- 19 Pages
Russia
From €2862EUR$2,995USD£2,435GBP
- Report
- October 2020
- 18 Pages
Brazil
From €2862EUR$2,995USD£2,435GBP
- Report
- October 2020
- 18 Pages
Mexico
From €2862EUR$2,995USD£2,435GBP
- Report
- October 2020
- 18 Pages
Japan
From €2862EUR$2,995USD£2,435GBP
Clot Management Procedure is a surgical procedure used to treat blood clots in the body. It involves the use of a catheter to deliver clot-dissolving drugs, such as tissue plasminogen activator (tPA), to the affected area. The procedure is typically performed in a hospital setting, and is often used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). Clot management procedures can also be used to treat stroke, heart attack, and other conditions.
The clot management procedure market is expected to grow in the coming years due to the increasing prevalence of cardiovascular diseases and the rising demand for minimally invasive treatments. The market is also driven by the increasing number of clinical trials and the development of new technologies.
Some of the major companies in the clot management procedure market include Boston Scientific Corporation, Medtronic, Abbott Laboratories, Johnson & Johnson, and Terumo Corporation. Show Less Read more